0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

The Future of mHealth
February 20, 2017
mHealth solutions in Asthma

mHealth has become a growing phenomenon within the healthcare industry. Society is increasingly dealing with an ageing population, an increase of ill health related to work and stress, and constraints on healthcare budgets. The way we monitor, store and learn to use our medication is changing but how quickly?

Why mHealth?

By using the powerful analytics healthcare apps can provide us with, digitally enabled care is almost becoming a necessity. For health and care services a single source is not enough anymore.  A tech savvy population are in control of how they bank, eat, live and transport themselves. Yet diagnosing themselves and having information on hand to aid self-diagnoses is scarce. mHealth solutions present us with the ability to log information related to personal health at the touch of a screen. With over 100,000 health apps in the market and with a forecast of 1.7 billion downloads of mhealth app on iOS and Android by 2017, there is plenty of room for more apps with better and personalised outcomes.

The mHealth Market

Initially, the mobile health industry was a marketplace dominated by health and fitness apps such as MyFitnessPal or wearables such as Fitbit. However, the growth is now in remote consultation and monitoring. Now, mobile health apps can aid in the management of asthma, cancer and diabetes. In the UK alone, 4 out of 5 adults will have a smartphone and 70% of all older patients in the UK want to use digital healthcare. From 2014 to 2018 mHealth apps are predicted to grow by 35% in the UK alone. The growth of the mHealth industry is however not just restricted to the UK. Globally, between the same timeframe, there will be an estimated growth of 49%. In 2017 the market will account for over $23 Billion. By 2018, Europe will be the largest mobile health market in the world.

The mHealth industry is growing, diversifying and expectation is high. From health and fitness dominated apps, to a growth in remote monitoring and consultation. In an age where tech is the future and a single health and care service is not enough, this tech savvy population are taking matters into their own hands.

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...